Jannie S Baker

Title: Jannie S. Baker – A Pioneer in Pharmaceutical Innovation

Introduction

Jannie S. Baker is a notable inventor based in White Plains, NY, who has made significant contributions to the field of pharmaceuticals. With her innovative spirit and dedication to research, she has secured two patents that showcase her expertise in developing new therapeutic agents.

Latest Patents

Among her latest inventions are two pivotal patents. The first patent involves 1-substituted-1,2-dihydro-4-((substituted)phenyl)imidazo-[1,5-a]pyrimidine-8-carbonitriles. This disclosure outlines compounds that have potential uses as antihypertensive agents and antidepressant agents in mammals, providing new avenues for the treatment of these conditions. The second patent covers substituted-phenyl-1,2,4-triazolo[4,3-c]pyrimidines. This innovation describes novel 5-, 7-, and 8-(substituted-phenyl)-1,2,4-triazolo[4,3-c]pyrimidines and their application as anxiolytic agents, offering therapeutic solutions for anxiety disorders.

Career Highlights

Jannie S. Baker is associated with American Cyanamid Company, where her work focuses on advancing pharmaceutical research and development. Her contributions to the field underscore her role as a leading inventor who bridges science and practical healthcare solutions.

Collaborations

Throughout her career, Jannie has had the opportunity to collaborate with esteemed coworkers, including Robert A. Hardy, Jr. and Nicanor Quinones Quinones. These collaborations have further enriched her research endeavors and facilitated the development of novel medicinal compounds.

Conclusion

Jannie S. Baker’s dedication to innovation in pharmaceuticals exemplifies the impact of thoughtful invention in addressing critical health issues. Her patents not only signify her impressive capabilities as an inventor but also hold promise for improving patient outcomes in the medical field.